Citation Impact
Citing Papers
Whole-genome resequencing reveals loci under selection during chicken domestication
2010 StandoutNature
Expansive discovery of chemically diverse structured macrocyclic oligoamides
2024 StandoutScienceNobel
TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition
2006
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
2016
A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes
2008
Inflammatory links between obesity and metabolic disease
2011 Standout
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Brown and beige fat: development, function and therapeutic potential
2013 Standout
Identification and Importance of Brown Adipose Tissue in Adult Humans
2009 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials
2007
SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis
2016
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
2008 Standout
Selective Inhibition of Eukaryotic Translation Initiation Factor 2α Dephosphorylation Potentiates Fatty Acid-induced Endoplasmic Reticulum Stress and Causes Pancreatic β-Cell Dysfunction and Apoptosis
2006
Diabetic Painful and Insensate Neuropathy: Pathogenesis and Potential Treatments
2009
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’
2007
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice
2008
Dramatic Accumulation of Triglycerides and Precipitation of Cardiac Hemodynamic Dysfunction during Brief Caloric Restriction in Transgenic Myocardium Expressing Human Calcium-independent Phospholipase A2γ
2007
Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
2019
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
2016 StandoutNobel
Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues
2011
Type 2 diabetes as an inflammatory disease
2011 Standout
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
2014
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
2012 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
2014
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Highly water-soluble platinum(ii) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties
2013
Type 2 diabetes
2017 Standout
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
NF-κB, Inflammation, and Metabolic Disease
2011 Standout
Treatment for diabetic foot ulcers
2005
Optimising Antimicrobial Therapy in Diabetic Foot Infections
2007
Type 1 diabetes
2013 Standout
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Visceral Obesity and Insulin Resistance as Risk Factors for Colorectal Adenoma: A Cross-Sectional, Case–Control Study
2009
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
2017 Standout
The role of the kidneys in glucose homeostasis in type 2 diabetes: Clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors
2014
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
2017
Sulforaphane protects against cytokine- and streptozotocin-induced β-cell damage by suppressing the NF-κB pathway
2008
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes
2014
Type 2 diabetes mellitus
2015 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
2017
Phenotypes of prediabetes and stratification of cardiometabolic risk
2016
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Trends in peptide drug discovery
2021
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
2015
Cellular senescence: from physiology to pathology
2014 Standout
Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
2018
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial
2005 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice
2008 Standout
Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor
2006
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
2010
Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta‐analysis
2016
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
2015
Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences
2015
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Inflammatory Mechanisms in Obesity
2011 Standout
Glucose and leptin induce apoptosis in human β‐ cells and impair glucose‐stimulated insulin secretion through activation of c‐Jun N‐terminal kinases
2008
Mechanisms of Diabetic Complications
2013 Standout
Changes in MicroRNA Expression Contribute to Pancreatic β-Cell Dysfunction in Prediabetic NOD Mice
2012
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema
2016
The safety of dipeptidyl peptidase‐4 (DPP‐4) inhibitors or sodium‐glucose cotransporter 2 (SGLT‐2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis
2013
Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes
2008
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
2015
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
2011
The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents
2014
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
C-Peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277
2011
Works of Roy Eldor being referenced
Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study
2013
Treatment of new‐onset type 1 diabetes with peptide DiaPep277® is safe and associated with preserved beta‐cell function: extension of a randomized, double‐blind, phase II trial
2006
New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies
2004
Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage
2004
Novel Glucagon-like Peptide-1 Analog Delivered Orally Reduces Postprandial Glucose Excursions in Porcine and Canine Models
2010
Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
2013
Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms
2011
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
2014
Chronic Reduction of Plasma Free Fatty Acid Improves Mitochondrial Function and Whole-Body Insulin Sensitivity in Obese and Type 2 Diabetic Individuals
2013
In Vivo Actions of Peroxisome Proliferator–Activated Receptors
2013
Lipotoxicity versus adipotoxicity—The deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes
2006
Conditional and specific NF-κB blockade protects pancreatic beta cells from diabetogenic agents
2006